Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Amarin reported $301.28M in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
Amarin AMRN:US USD 301.28M 2.28M
AstraZeneca AZN:LN USD 387M 0
Esperion Therapeutics ESPR:US USD 87K 12K
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
Halozyme Therapeutics HALO:US USD 132K 3K
Heron Therapeutics HRTX:US USD 1.19M 2K
Intercept Pharmaceuticals ICPT:US USD 42K 0
Ionis Pharmaceuticals IONS:US USD 143K 1000
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 842M 48M